首页 > 最新文献

Paediatric Respiratory Reviews最新文献

英文 中文
Intravenous magnesium sulfate for asthma exacerbations in children: Systematic review with meta-analysis 静脉注射硫酸镁治疗儿童哮喘加重:系统综述与荟萃分析
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-12-01 Epub Date: 2024-02-12 DOI: 10.1016/j.prrv.2024.01.003
Dominika Ambrożej , Aleksander Adamiec , Erick Forno , Izabela Orzołek , Wojciech Feleszko , Jose A. Castro-Rodriguez

Background

Asthma is the most prevalent chronic disease in children and constitutes a significant healthcare burden. First-line therapy for acute asthma exacerbations is well established. However, secondary treatments, including intravenous magnesium sulfate (IV-MgSO4), remain variable due to scarcity of data on its efficacy and safety.

Objective

To assess the effectiveness and safety of IV-MgSO4 as a second line of treatment in managing children with asthma exacerbations.

Methods

We searched five databases from inception until April 2023 on randomized clinical trials of IV-MgSO4 in children with acute asthma exacerbations. The primary outcomes were hospitalization rate and length, and change in the severity score. Secondary outcomes included percentage increase in peak expiratory flow rate (PEFR), hospital re-admission rate, need and length for pediatric intensive care unit (PICU) treatment, and adverse effects. Meta-analysis was performed for three outcomes with estimated odds ratios (ORs) or mean differences (MDs) and 95% confidence intervals (CIs).

Results

Eleven studies met the final criteria. In comparison to control, administration of IV-MgSO4 was associated with a reduced hospitalization risk (OR 0.15; 95%CI: 0.03, 0.73) in four studies, and improvement of lung function (MD 26.77% PEFR; 95%CI: 18.41, 54.79) in two studies. There were no significant differences in the length of stay between groups. Due to heterogeneity, a narrative synthesis of other outcomes was performed.

Conclusion

The use of IV-MgSO4 demonstrated a reduction in the hospitalization rate and PEFR improvement in children with asthma exacerbations. Adverse effects were rare. Further well-designed studies are needed to better determine the efficacy and safety profile of IV-MgSO4.
背景:哮喘是儿童中最常见的慢性疾病,构成了重大的医疗负担。急性哮喘加重的一线治疗方法已经建立。然而,二次治疗,包括静脉注射硫酸镁(IV-MgSO4),由于缺乏其有效性和安全性的数据,仍然是可变的。目的评价IV-MgSO4作为治疗儿童哮喘加重的二线药物的有效性和安全性。方法:我们检索了5个数据库,从建立到2023年4月,IV-MgSO4在急性哮喘发作儿童中的随机临床试验。主要结局是住院率和住院时间,以及严重程度评分的变化。次要结局包括呼气峰流量(PEFR)的百分比增加、再入院率、儿科重症监护病房(PICU)治疗的需求和时间以及不良反应。对三个结果进行meta分析,估计优势比(ORs)或平均差异(MDs)和95%置信区间(CIs)。结果6项研究符合最终标准。与对照组相比,IV-MgSO4的使用与住院风险降低相关(OR 0.15;95%CI: 0.03, 0.73),肺功能改善(MD 26.77% PEFR;95%CI: 18.41, 54.79)。两组患者的住院时间没有显著差异。由于异质性,对其他结果进行叙事综合。结论使用IV-MgSO4可降低哮喘患儿住院率,改善PEFR。副作用很少。需要进一步精心设计的研究来更好地确定IV-MgSO4的有效性和安全性。
{"title":"Intravenous magnesium sulfate for asthma exacerbations in children: Systematic review with meta-analysis","authors":"Dominika Ambrożej ,&nbsp;Aleksander Adamiec ,&nbsp;Erick Forno ,&nbsp;Izabela Orzołek ,&nbsp;Wojciech Feleszko ,&nbsp;Jose A. Castro-Rodriguez","doi":"10.1016/j.prrv.2024.01.003","DOIUrl":"10.1016/j.prrv.2024.01.003","url":null,"abstract":"<div><h3>Background</h3><div>Asthma is the most prevalent chronic disease<span> in children and constitutes a significant healthcare burden. First-line therapy for acute asthma exacerbations is well established. However, secondary treatments, including intravenous magnesium sulfate (IV-MgSO4), remain variable due to scarcity of data on its efficacy and safety.</span></div></div><div><h3>Objective</h3><div>To assess the effectiveness and safety of IV-MgSO4 as a second line of treatment in managing children with asthma exacerbations.</div></div><div><h3>Methods</h3><div><span>We searched five databases from inception until April 2023 on randomized clinical trials of IV-MgSO4 in children with acute asthma exacerbations. The primary outcomes were hospitalization rate and length, and change in the severity score. Secondary outcomes included percentage increase in </span>peak expiratory flow rate<span><span> (PEFR), hospital re-admission rate, need and length for pediatric intensive care unit (PICU) treatment, and </span>adverse effects. Meta-analysis was performed for three outcomes with estimated odds ratios (ORs) or mean differences (MDs) and 95% confidence intervals (CIs).</span></div></div><div><h3>Results</h3><div>Eleven studies met the final criteria. In comparison to control, administration of IV-MgSO4 was associated with a reduced hospitalization risk (OR 0.15; 95%CI: 0.03, 0.73) in four studies, and improvement of lung function (MD 26.77% PEFR; 95%CI: 18.41, 54.79) in two studies. There were no significant differences in the length of stay between groups. Due to heterogeneity, a narrative synthesis of other outcomes was performed.</div></div><div><h3>Conclusion</h3><div>The use of IV-MgSO4 demonstrated a reduction in the hospitalization rate and PEFR improvement in children with asthma exacerbations. Adverse effects were rare. Further well-designed studies are needed to better determine the efficacy and safety profile of IV-MgSO4.</div></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"52 ","pages":"Pages 23-30"},"PeriodicalIF":4.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139875941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Necrotizing Pneumonia In Children: A Review 儿童坏死性肺炎:综述
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-12-01 Epub Date: 2024-02-20 DOI: 10.1016/j.prrv.2024.02.003
Helena Teresinha Mocelin , Gilberto Bueno Fischer , Júlia Danezi Piccini , Júlio de Oliveira Espinel , Cristiano Feijó Andrade , Andrew Bush
The objective of the review was to determine the long-term outcomes of necrotising pneumonia (NP). Studies published since 1990 in English, Portuguese, or Spanish, published on PubMed and Scielo were evaluated. Our findings showed ultrasound scanning is the diagnostic modality of choice. Despite prolonged hospitalisation (median 13–27 days) and fever (median 9–16 days), most patients recover completely. Empyema and bronchopleural fistulae are frequent in bacterial NP. Streptococcus pneumoniae is the most prevalent cause. Seventeen studies with 497 patients followed for 30 days to 8.75 years showed that most patients were clinically asymptomatic and had normal lung function. X-ray or CT chest imaging demonstrated that almost all lung lesions recovered within 4–6 months. We suggest that it is not necessary to request frequent chest X-rays during the treatment and recovery process. Chest CT scans should be reserved for specific cases not following the expected clinical course.
本综述的目的是确定坏死性肺炎(NP)的长期预后。对1990年以来在PubMed和Scielo上发表的英语、葡萄牙语或西班牙语的研究进行了评估。我们的研究结果显示超声扫描是诊断方式的选择。尽管住院时间延长(中位13-27天)和发烧(中位9-16天),但大多数患者完全康复。脓胸和支气管胸膜瘘是细菌性NP的常见病。肺炎链球菌是最常见的病因。17项研究对497例患者进行了30天至8.75年的随访,结果显示大多数患者临床无症状,肺功能正常。x线或CT胸部成像显示几乎所有肺部病变在4-6个月内恢复。我们建议在治疗和恢复过程中没有必要要求频繁的胸部x光检查。胸部CT扫描应保留特定的情况下,不符合预期的临床过程。
{"title":"Necrotizing Pneumonia In Children: A Review","authors":"Helena Teresinha Mocelin ,&nbsp;Gilberto Bueno Fischer ,&nbsp;Júlia Danezi Piccini ,&nbsp;Júlio de Oliveira Espinel ,&nbsp;Cristiano Feijó Andrade ,&nbsp;Andrew Bush","doi":"10.1016/j.prrv.2024.02.003","DOIUrl":"10.1016/j.prrv.2024.02.003","url":null,"abstract":"<div><div>The objective of the review was to determine the long-term outcomes of necrotising pneumonia (NP). Studies published since 1990 in English, Portuguese, or Spanish, published on PubMed and Scielo were evaluated. Our findings showed ultrasound scanning is the diagnostic modality of choice. Despite prolonged hospitalisation (median 13–27 days) and fever (median 9–16 days), most patients recover completely. Empyema and bronchopleural fistulae are frequent in bacterial NP. <em>Streptococcus pneumoniae</em> is the most prevalent cause. Seventeen studies with 497 patients followed for 30 days to 8.75 years showed that most patients were clinically asymptomatic and had normal lung function. X-ray or CT chest imaging demonstrated that almost all lung lesions recovered within 4–6 months. We suggest that it is not necessary to request frequent chest X-rays during the treatment and recovery process. Chest CT scans should be reserved for specific cases not following the expected clinical course.</div></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"52 ","pages":"Pages 51-57"},"PeriodicalIF":4.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139927153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The wheezy infant: A viewpoint from low-middle income countries 喘息的婴儿:来自中低收入国家的观点。
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 Epub Date: 2022-06-25 DOI: 10.1016/j.prrv.2022.06.001

Objective

To review the recent evidence in the literature of various aspects of recurrent/severe wheezing in children under 3 in low-middle income countries [LMICS].

Sources

A non-systematic review including articles in English. We mainly selected publications from the last 5 years. Studies on epidemiology, aetiology, diagnosis, treatment, and prevention were included in the search. We reviewed differential diagnoses of wheezing that focused on LMICS. We also reviewed aspects of prevention.

Summary of the findings

Many epidemiological studies have shown a variable but significant number of wheezy infants [WI] cases in LMICS when compared to other countries.

The differential diagnosis of causes of wheezing in this age group is mandatory, taking into account local facilities.

Few treatment options have been well studied for this age group. In LMICS, a pragmatic approach could be considered, as described in the article.

It is difficult to study primary prevention for WI and secondary prevention (mainly environmental) may have some impact.

A schematic approach for recurrent wheezers is presented, which takes into account settings with limited resources.

Conclusion

Severely or recurrently wheezy children under 3 is a common clinical issue in LMICS. Studies on this age group are needed to reduce the significant morbidity. It may be possible to lower the high burden of wheezing in this age group by selecting the phenotype which may respond to inhaled steroids.

目的回顾中低收入国家(LMICS)3 岁以下儿童反复/严重喘息各方面的最新文献证据:资料来源:非系统性综述,包括英文文章。我们主要选择了过去 5 年中的出版物。检索包括有关流行病学、病因学、诊断、治疗和预防的研究。我们回顾了以 LMICS 为重点的喘息的鉴别诊断。我们还审查了预防的各个方面:许多流行病学研究表明,与其他国家相比,低收入国家的喘息婴儿 [WI] 病例数量不一,但数量可观。考虑到当地的设施,必须对这一年龄组的喘息病因进行鉴别诊断。针对这一年龄组的治疗方案鲜有研究。在低收入国家,可以考虑文章中所述的务实方法。很难研究 WI 的一级预防,二级预防(主要是环境)可能会有一些影响。文章介绍了针对反复喘息者的示意性方法,其中考虑到了资源有限的环境:结论:3 岁以下儿童喘息严重或反复发作是低收入国家常见的临床问题。需要对这一年龄组的儿童进行研究,以降低重大的发病率。通过选择可能对吸入类固醇有反应的表型,有可能降低这一年龄组的高喘息负担。
{"title":"The wheezy infant: A viewpoint from low-middle income countries","authors":"","doi":"10.1016/j.prrv.2022.06.001","DOIUrl":"10.1016/j.prrv.2022.06.001","url":null,"abstract":"<div><h3>Objective</h3><p>To review the recent evidence in the literature of various aspects of recurrent/severe wheezing in children under 3 in low-middle income countries [LMICS].</p></div><div><h3>Sources</h3><p>A non-systematic review including articles in English. We mainly selected publications from the last 5 years. Studies on epidemiology, aetiology, diagnosis, treatment, and prevention were included in the search. We reviewed differential diagnoses of wheezing that focused on LMICS. We also reviewed aspects of prevention.</p></div><div><h3>Summary of the findings</h3><p>Many epidemiological studies have shown a variable but significant number of wheezy infants [WI] cases in LMICS when compared to other countries.</p><p>The differential diagnosis of causes of wheezing in this age group is mandatory, taking into account local facilities.</p><p>Few treatment options have been well studied for this age group. In LMICS, a pragmatic approach could be considered, as described in the article.</p><p>It is difficult to study primary prevention for WI and secondary prevention (mainly environmental) may have some impact.</p><p>A schematic approach for recurrent wheezers is presented, which takes into account settings with limited resources.</p></div><div><h3>Conclusion</h3><p>Severely or recurrently wheezy children under 3 is a common clinical issue in LMICS. Studies on this age group are needed to reduce the significant morbidity. It may be possible to lower the high burden of wheezing in this age group by selecting the phenotype which may respond to inhaled steroids.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 32-37"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40560748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simulation based education in paediatric resuscitation 儿科复苏模拟教育
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 Epub Date: 2024-05-11 DOI: 10.1016/j.prrv.2024.05.002

There is increasing use of clinical Simulation Based Education (SBE) in healthcare due to an increased focus on patient safety, the call for a new training model not based solely on apprenticeship, a desire for standardised educational opportunities that are available on-demand, and a need to practice and hone skills in a controlled environment. SBE programs should be evaluated against Kirkpatrick level 3 or 4 criteria to ensure they improve patient or staff outcomes in the real world. SBE programs have been shown to improve outcomes in neonatology – reductions in hypoxic ischaemic encephalopathy, in brachial plexus injury, rates of school age cerebral palsy, reductions in 24hr mortality and improvements in first pass intubation rates. In paediatrics SBE programs have shown improvements in paediatric cardiac arrest survival, PICU survival, reduced PICU admissions, reduced PICU length of stay and reduced time to critical operations. SBE can improve the non-technical tasks of teamwork, leadership and communication (within the team and with patients and carers). Simulation is a useful tool in Quality and Safety and is used to identify latent safety issues that can be addressed by future programs. In high stakes assessment simulation can be a mode of assessment, however, care needs to be taken to ensure the tool is validated carefully.

在医疗保健领域,临床模拟教育(SBE)的使用越来越多,这是因为人们越来越重视患者安全,呼吁建立一种新的培训模式,而不仅仅是学徒制,希望有按需提供的标准化教育机会,以及需要在可控环境中练习和磨练技能。应根据 Kirkpatrick 3 级或 4 级标准对 SBE 项目进行评估,以确保它们能在现实世界中改善患者或员工的治疗效果。事实证明,SBE 项目可改善新生儿科的治疗效果--减少缺氧缺血性脑病、臂丛神经损伤、学龄期脑瘫发生率、降低 24 小时死亡率并提高首次插管率。在儿科领域,SBE 计划提高了儿科心脏骤停患者的存活率、重症监护病房的存活率,减少了重症监护病房的入院人数,缩短了重症监护病房的住院时间,缩短了重症手术的时间。SBE 可以改善团队合作、领导力和沟通(团队内部以及与患者和护理人员)等非技术性任务。模拟是质量与安全方面的一个有用工具,可用于发现潜在的安全问题,并在今后的计划中加以解决。在高风险评估中,模拟可以作为一种评估模式,但需要注意确保该工具经过认真验证。
{"title":"Simulation based education in paediatric resuscitation","authors":"","doi":"10.1016/j.prrv.2024.05.002","DOIUrl":"10.1016/j.prrv.2024.05.002","url":null,"abstract":"<div><p>There is increasing use of clinical Simulation Based Education (SBE) in healthcare due to an increased focus on patient safety, the call for a new training model not based solely on apprenticeship, a desire for standardised educational opportunities that are available on-demand, and a need to practice and hone skills in a controlled environment. SBE programs should be evaluated against Kirkpatrick level 3 or 4 criteria to ensure they improve patient or staff outcomes in the real world. SBE programs have been shown to improve outcomes in neonatology – reductions in hypoxic ischaemic encephalopathy, in brachial plexus injury, rates of school age cerebral palsy, reductions in 24hr mortality and improvements in first pass intubation rates. In paediatrics SBE programs have shown improvements in paediatric cardiac arrest survival, PICU survival, reduced PICU admissions, reduced PICU length of stay and reduced time to critical operations. SBE can improve the non-technical tasks of teamwork, leadership and communication (within the team and with patients and carers). Simulation is a useful tool in Quality and Safety and is used to identify latent safety issues that can be addressed by future programs. In high stakes assessment simulation can be a mode of assessment, however, care needs to be taken to ensure the tool is validated carefully.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 2-9"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1526054224000460/pdfft?md5=1205c6e575e72b7577f6230986913dcf&pid=1-s2.0-S1526054224000460-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141037431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulse oximetry in patients with pigmented skin: What I should know 色素性皮肤患者的脉搏血氧仪:我应该知道什么
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 Epub Date: 2024-06-05 DOI: 10.1016/j.prrv.2024.06.001

Pulse oximetry is widely used to non-invasively estimate the oxygen saturation of haemoglobin in arterial blood (SpO2). It is used widely throughout healthcare and was used extensively during the Covid-19 pandemic to detect and treat hypoxic patients. Research has suggested that pulse oximetry is less accurate in patients with darker skin. This led the US Food and Drug Administration agency (FDA) to issue a safety statement warning that pulse oximeters may be inaccurate when patients have pigmented skin.

Evidence suggests that the oxygen saturation of arterial blood (SaO2) may be being overestimated by measuring SpO2 in those with pigmented skin. The degree of overestimation increases as SaO2 decreases especially when SpO2 reads below 80%. We review how pulse oximetry works and consider the implications for a patient’s health when interpreting SpO2 in individuals with pigmented skin.

脉搏血氧仪被广泛用于无创估算动脉血中血红蛋白的氧饱和度(SpO2)。脉搏血氧仪被广泛应用于医疗保健领域,并在 Covid-19 大流行期间被广泛用于检测和治疗缺氧患者。研究表明,脉搏血氧仪在皮肤较黑的患者中准确性较低。这导致美国食品和药物管理局 (FDA) 发布了一份安全声明,警告说当患者皮肤有色素沉着时,脉搏血氧仪可能会不准确。高估的程度会随着 SaO2 的降低而增加,尤其是当 SpO2 低于 80% 时。我们回顾了脉搏血氧仪的工作原理,并考虑了在解释色素性皮肤患者的 SpO2 时对患者健康的影响。
{"title":"Pulse oximetry in patients with pigmented skin: What I should know","authors":"","doi":"10.1016/j.prrv.2024.06.001","DOIUrl":"10.1016/j.prrv.2024.06.001","url":null,"abstract":"<div><p><span>Pulse oximetry<span> is widely used to non-invasively estimate the oxygen saturation of haemoglobin in arterial blood (SpO</span></span><sub>2</sub>). It is used widely throughout healthcare and was used extensively during the Covid-19 pandemic to detect and treat hypoxic patients. Research has suggested that pulse oximetry is less accurate in patients with darker skin. This led the US Food and Drug Administration agency (FDA) to issue a safety statement warning that pulse oximeters may be inaccurate when patients have pigmented skin.</p><p>Evidence suggests that the oxygen saturation of arterial blood (SaO<sub>2</sub>) may be being overestimated by measuring SpO<sub>2</sub> in those with pigmented skin. The degree of overestimation increases as SaO<sub>2</sub> decreases especially when SpO<sub>2</sub> reads below 80%. We review how pulse oximetry works and consider the implications for a patient’s health when interpreting SpO<sub>2</sub> in individuals with pigmented skin.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 19-25"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141399961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating simulation teaching into acute clinical paediatrics 将模拟教学融入急诊儿科临床
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 Epub Date: 2024-05-17 DOI: 10.1016/j.prrv.2024.05.003
{"title":"Integrating simulation teaching into acute clinical paediatrics","authors":"","doi":"10.1016/j.prrv.2024.05.003","DOIUrl":"10.1016/j.prrv.2024.05.003","url":null,"abstract":"","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Page 1"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141050345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of peak cough flow and peak expiratory flow in children with neuromuscular disorders 神经肌肉障碍儿童咳嗽峰值流速与呼气峰值流速的比较
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 Epub Date: 2024-04-04 DOI: 10.1016/j.prrv.2024.04.001

Spirometry and peak cough flow testing (PCF) are commonly used in the respiratory assessment of children with a neuromuscular disorder (NMD). Testing uses two different machines, increases laboratory time, costs and resource utilisation. No studies have assessed the correlation between peak expiratory flow (PEF) obtained from spirometry and PCF in children with NMD using one device. An audit of children with a NMD managed at the Children’s Hospital at Westmead in 2022–2024 aged < 20 years who performed spirometry and PCF testing on the same device (Vyaire Body BoxTM, Ultrasonic flow meter-based, or Vyaire PneumotachographTM, Pneumotach flow meter-based; Germany) was conducted to assess the correlation between PCF and PEF. Fifty-one sets of testing were identified, and 40 subjects (9F) had reproducible testing and were included. Median (range) age was 14.95 (7.20–19.00) years. Median PEF (L/min) was 4.05 (1.22–10.26) and median PCF (L/min) was 4.29 (1.69–10.82). PEF and PCF had a strong Pearson’s correlation coefficient, (R = 0.97, p = 0.03). The coefficient of determination was 0.93. If laboratory resources permit, spirometry should be the test of choice for children with NMD. On average, spirometry required multiple practices to achieve reproducibility to meet ATS/ERS standards. PCF testing can be utilised for children where performing technically acceptable spirometry is not possible.

在对患有神经肌肉障碍(NMD)的儿童进行呼吸评估时,通常会使用肺活量和咳嗽峰流速测试(PCF)。测试使用两种不同的机器,增加了实验室时间、成本和资源利用率。目前还没有研究对使用一种设备对 NMD 儿童进行肺活量测定和 PCF 所获得的呼气峰值流速 (PEF) 之间的相关性进行评估。2022-2024 年,Westmead 儿童医院对年龄小于 20 岁、使用同一设备(德国 Vyaire Body Box,超声波流量计;或 Vyaire Pneumotachograph,气动流量计)进行肺活量和 PCF 测试的 NMD 患儿进行了审核,以评估 PCF 和 PEF 之间的相关性。共确定了 51 组测试,40 名受试者(9F)的测试结果具有可重复性,并被纳入其中。年龄中位数(范围)为 14.95(7.20-19.00)岁。中位 PEF(L/min)为 4.05(1.22-10.26),中位 PCF(L/min)为 4.29(1.69-10.82)。PEF 和 PCF 具有很强的皮尔逊相关系数(R = 0.97,P = 0.03)。判定系数为 0.93。如果实验室资源允许,应将肺活量测定作为 NMD 患儿的首选检测方法。平均而言,肺活量测定需要多次操作才能达到 ATS/ERS 标准的重现性要求。对于无法进行技术上可接受的肺活量测定的儿童,可使用 PCF 测试。
{"title":"A comparison of peak cough flow and peak expiratory flow in children with neuromuscular disorders","authors":"","doi":"10.1016/j.prrv.2024.04.001","DOIUrl":"10.1016/j.prrv.2024.04.001","url":null,"abstract":"<div><p><span><span>Spirometry and peak cough flow testing (PCF) are commonly used in the respiratory assessment of children with a </span>neuromuscular disorder (NMD). Testing uses two different machines, increases laboratory time, costs and resource utilisation. No studies have assessed the correlation between peak expiratory flow (PEF) obtained from spirometry and PCF in children with NMD using one device. An audit of children with a NMD managed at the Children’s Hospital at Westmead in 2022–2024 aged &lt; 20 years who performed spirometry and PCF testing on the same device (Vyaire Body Box</span><sup>TM</sup>, Ultrasonic flow meter-based, or Vyaire Pneumotachograph<sup>TM</sup>, Pneumotach flow meter-based; Germany) was conducted to assess the correlation between PCF and PEF. Fifty-one sets of testing were identified, and 40 subjects (9F) had reproducible testing and were included. Median (range) age was 14.95 (7.20–19.00) years. Median PEF (L/min) was 4.05 (1.22–10.26) and median PCF (L/min) was 4.29 (1.69–10.82). PEF and PCF had a strong Pearson’s correlation coefficient, (R = 0.97, p = 0.03). The coefficient of determination was 0.93. If laboratory resources permit, spirometry should be the test of choice for children with NMD. On average, spirometry required multiple practices to achieve reproducibility to meet ATS/ERS standards. PCF testing can be utilised for children where performing technically acceptable spirometry is not possible.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 26-31"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140577331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to deliver effective paediatric simulation based education 如何有效开展儿科模拟教学
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 Epub Date: 2024-05-15 DOI: 10.1016/j.prrv.2024.05.001

Simulation based education (SBE) is an educational tool increasingly used in the approach to the initial and ongoing education of healthcare professionals. Like all education tools, SBE needs to be used appropriately to achieve the desired outcomes. Using Cognitive Load Theory (CLT) in the instructional design of simulations is essential to maximise participant learning by reducing extraneous load and optimising intrinsic load. Educators can modify task fidelity, task complexity and instructional support to optimise learning. Specific methodologies can be used in program design such as rapid cycle deliberate practice, round the table teaching, low dose high frequency and flipped classroom. Fidelity and authenticity are important factors to consider when choosing design elements to ensure learner engagement, but not to overwhelm cognitive load. An integral part of SBE is the feedback or debriefing component. Several evidence-based methodologies can be employed to facilitate post simulation learning, including Debriefing with Good Judgement and PEARLS. Educators also need to consider faculty education and development, such as the discovery, growth and maturity model.

模拟教育(SBE)是一种教育工具,越来越多地被用于医疗保健专业人员的初始教育和继续教育。与所有教育工具一样,SBE 也需要合理使用才能达到预期效果。在模拟教学设计中使用认知负荷理论(CLT)对于通过减少外在负荷和优化内在负荷最大限度地提高参与者的学习效果至关重要。教育者可以修改任务保真度、任务复杂度和教学支持,以优化学习效果。在项目设计中可以使用特定的方法,如快速循环刻意练习、圆桌教学、低剂量高频率和翻转课堂。在选择设计元素时,保真度和真实性是需要考虑的重要因素,以确保学习者的参与度,但又不会加重认知负担。反馈或汇报是 SBE 不可分割的一部分。可以采用几种基于证据的方法来促进模拟后学习,包括 "良好判断汇报 "和 "PEARLS"。教育者还需要考虑教师的教育和发展,如发现、成长和成熟模型。
{"title":"How to deliver effective paediatric simulation based education","authors":"","doi":"10.1016/j.prrv.2024.05.001","DOIUrl":"10.1016/j.prrv.2024.05.001","url":null,"abstract":"<div><p>Simulation based education (SBE) is an educational tool increasingly used in the approach to the initial and ongoing education of healthcare professionals. Like all education tools, SBE needs to be used appropriately to achieve the desired outcomes. Using Cognitive Load Theory (CLT) in the instructional design of simulations is essential to maximise participant learning by reducing extraneous load and optimising intrinsic load. Educators can modify task fidelity, task complexity and instructional support to optimise learning. Specific methodologies can be used in program design such as rapid cycle deliberate practice, round the table teaching, low dose high frequency and flipped classroom. Fidelity and authenticity are important factors to consider when choosing design elements to ensure learner engagement, but not to overwhelm cognitive load. An integral part of SBE is the feedback or debriefing component. Several evidence-based methodologies can be employed to facilitate post simulation learning, including Debriefing with Good Judgement and PEARLS. Educators also need to consider faculty education and development, such as the discovery, growth and maturity model.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 10-18"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1526054224000459/pdfft?md5=383550ee0f562b49b2974a43484a2a11&pid=1-s2.0-S1526054224000459-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Antibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care” "囊性纤维化中的抗生素超敏反应:彻底检查患者护理中的绊脚石"
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 Epub Date: 2024-02-12 DOI: 10.1016/j.prrv.2024.01.004

One hurdle in the management of CF, a disease characterized by progressive endobronchial infection, is the presence of hypersensitivity reactions to antimicrobials due to prolonged and repetitive treatment courses. The aim of this review is to compile existing data and provide insight to medical professionals on a long-debated topic for optimum patient care. Clinical studies were inducted from the last 15 years and filtered based on their relativity to drug hypersensitivity reactions (DHRs), antibiotics and CF. After completing the selection process, 10 clinical studies were thoroughly examined. The most frequent antibiotic group related to DHRs were beta-lactams. Frequency of the most common overall type of reaction (immediate or nonimmediate) differed among clinical studies. Although severe reactions seem rare comparatively, they do occur during and even after completion of treatment regimens. The prevalence of true drug allergies should be confirmed using a variety of tests available, however, should not be confused with overall DHR rates. Genetic mutations, gender and lifetime antibiotic dose were not related with an increased risk for DHR development. On the contrary, the most important factor according to most studies was the cumulative antimicrobial dose in a given period of time, especially when delivered parenterally. DHRs are an indisputable problem in the management of CF patients. Understanding possible risk factors and increased awareness is vital in both hospital and outpatient settings as early detection can decrease the severity of the reactions.

CF 是一种以进行性支气管内感染为特征的疾病,其治疗过程中的一个障碍是由于长期和重复的治疗过程而导致的对抗菌药物的超敏反应。本综述旨在汇编现有数据,并就这一长期争论的话题为医疗专业人员提供见解,以优化患者护理。本综述收集了过去 15 年中的临床研究,并根据其与药物超敏反应(DHR)、抗生素和 CF 的相关性进行了筛选。在完成筛选过程后,对 10 项临床研究进行了全面检查。与药物过敏反应相关的最常见抗生素组别是β-内酰胺类。各临床研究中最常见的总体反应类型(即刻反应或非即刻反应)的发生率各不相同。虽然严重的反应似乎比较罕见,但在治疗过程中甚至在治疗结束后确实会发生。真正的药物过敏发生率应使用现有的各种检测方法进行确认,但不应与总体 DHR 发生率相混淆。基因突变、性别和终生抗生素剂量与 DHR 发生风险的增加无关。相反,根据大多数研究,最重要的因素是特定时间内累积的抗菌剂剂量,尤其是经肠外给药时。DHR 是 CF 患者管理中一个无可争议的问题。在医院和门诊环境中,了解可能的风险因素并提高意识至关重要,因为早期发现可降低反应的严重程度。
{"title":"“Antibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care”","authors":"","doi":"10.1016/j.prrv.2024.01.004","DOIUrl":"10.1016/j.prrv.2024.01.004","url":null,"abstract":"<div><p>One hurdle in the management of CF<span>, a disease characterized by progressive endobronchial infection, is the presence of hypersensitivity reactions to antimicrobials due to prolonged and repetitive treatment courses. The aim of this review is to compile existing data and provide insight to medical professionals on a long-debated topic for optimum patient care. Clinical studies were inducted from the last 15 years and filtered based on their relativity to drug hypersensitivity<span><span> reactions (DHRs), antibiotics and CF. After completing the selection process, 10 clinical studies were thoroughly examined. The most frequent antibiotic<span> group related to DHRs were beta-lactams. Frequency of the most common overall type of reaction (immediate or nonimmediate) differed among clinical studies. Although severe reactions seem rare comparatively, they do occur during and even after completion of treatment regimens. The prevalence of true drug allergies should be confirmed using a variety of tests available, however, should not be confused with overall DHR rates. </span></span>Genetic mutations, gender and lifetime antibiotic dose were not related with an increased risk for DHR development. On the contrary, the most important factor according to most studies was the cumulative antimicrobial dose in a given period of time, especially when delivered parenterally. DHRs are an indisputable problem in the management of CF patients. Understanding possible risk factors and increased awareness is vital in both hospital and outpatient settings as early detection can decrease the severity of the reactions.</span></span></p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 56-65"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139815878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of maternal asthma on the fetal lung: Outcomes, mechanisms and interventions 母体哮喘对胎儿肺部的影响:结果、机制和干预措施
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 Epub Date: 2023-12-23 DOI: 10.1016/j.prrv.2023.12.004

Maternal asthma affects up to 17% of pregnancies and is associated with adverse infant, childhood, and adult respiratory outcomes, including increased risks of neonatal respiratory distress syndrome, childhood wheeze and asthma. In addition to genetics, these poor outcomes are likely due to the mediating influence of maternal asthma on the in-utero environment, altering fetal lung and immune development and predisposing the offspring to later lung disease. Maternal asthma may impair glucocorticoid signalling in the fetus, a process critical for lung maturation, and increase fetal exposure to proinflammatory cytokines. Therefore, interventions to control maternal asthma, increase glucocorticoid signalling in the fetal lung, or Vitamin A, C, and D supplementation to improve alveologenesis and surfactant production may be beneficial for later lung function. This review highlights potential mechanisms underlying maternal asthma and offspring respiratory morbidities and describes how pregnancy interventions can promote optimal fetal lung development in babies of asthmatic mothers.

产妇哮喘影响到高达 17% 的孕妇,并与婴儿、儿童和成人呼吸系统的不良后果有关,包括新生儿呼吸窘迫综合征、儿童喘息和哮喘的风险增加。除遗传因素外,这些不良后果很可能是由于母体哮喘对子宫内环境的介导影响,改变了胎儿肺部和免疫系统的发育,使后代日后易患肺部疾病。母体哮喘可能会损害胎儿体内糖皮质激素信号的传递(这是肺成熟的关键过程),并增加胎儿暴露于促炎细胞因子的机会。因此,采取干预措施控制母体哮喘、增加胎儿肺中的糖皮质激素信号,或补充维生素 A、C 和 D 以改善肺泡生成和表面活性物质的产生,可能对日后的肺功能有益。本综述强调了母体哮喘和后代呼吸系统疾病的潜在机制,并介绍了妊娠干预措施如何促进哮喘母亲的胎儿肺部发育达到最佳状态。
{"title":"The impact of maternal asthma on the fetal lung: Outcomes, mechanisms and interventions","authors":"","doi":"10.1016/j.prrv.2023.12.004","DOIUrl":"10.1016/j.prrv.2023.12.004","url":null,"abstract":"<div><p>Maternal asthma affects up to 17% of pregnancies and is associated with adverse infant, childhood, and adult respiratory outcomes, including increased risks of neonatal respiratory distress syndrome, childhood wheeze and asthma. In addition to genetics, these poor outcomes are likely due to the mediating influence of maternal asthma on the <em>in-utero</em> environment, altering fetal lung and immune development and predisposing the offspring to later lung disease. Maternal asthma may impair glucocorticoid signalling in the fetus, a process critical for lung maturation, and increase fetal exposure to proinflammatory cytokines. Therefore, interventions to control maternal asthma, increase glucocorticoid signalling in the fetal lung, or Vitamin A, C, and D supplementation to improve alveologenesis and surfactant production may be beneficial for later lung function. This review highlights potential mechanisms underlying maternal asthma and offspring respiratory morbidities and describes how pregnancy interventions can promote optimal fetal lung development in babies of asthmatic mothers.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 38-45"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1526054223000866/pdfft?md5=1add1cb172faa202e6b911055c66cf87&pid=1-s2.0-S1526054223000866-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139020502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Paediatric Respiratory Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1